Glioblastome sind sehr aggressive Hirntumore. Die Erkrankung kann bisher nicht geheilt werden. Ein #CochraneReview schaut sich die verfügbare Evidenz zu verfügbaren Medikamenten an. Hier auf #CochraneKompakt: https://t.co/I2Flm9z6Y7 https://t.co/tGncA43ZdW
RT @CochraneLibrary: Drugs that target abnormal growth protein in high‐grade, aggressive brain tumours https://t.co/7pc9MqmkPF New systemat…
Drugs that target abnormal growth protein in high‐grade, aggressive brain tumours https://t.co/7pc9MqmkPF New systematic review from @cohrane_GN found 9 eligible studies for inclusion in the review. #Glioblastomas
Drugs that target abnormal growth protein in high‐grade, aggressive brain tumours https://t.co/PuxRlkNMkk New systematic review from @cohrane_GN found 9 eligible studies for inclusion in the review. #Glioblastomas
RT @Cochrane_GNOCG: New review.... https://t.co/mWuY4quVvu https://t.co/RAZuheOv7t
RT @Cochrane_GNOCG: New review.... https://t.co/mWuY4quVvu https://t.co/RAZuheOv7t
New review.... https://t.co/mWuY4quVvu https://t.co/RAZuheOv7t
Drugs that target abnormal growth protein in high‐grade, aggressive brain tumours https://t.co/h89S9t8lVE New systematic review from @Cochrane_GNOCG found 9 eligible studies for inclusion in the review. #Glioblastomas